Evidence map›Paper›PMID 33986547›Full record

ArticleNature biotechnology2022

Author Correction: CRISPR prime editing with ribonucleoprotein complexes in zebrafish and primary human cells.

Karl Petri, Weiting Zhang, Junyan Ma, Andrea Schmidts, Hyunho Lee, Joy E Horng, Daniel Y Kim, Ibrahim C Kurt, Kendell Clement, Jonathan Y Hsu and 4 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Deconstructing cancer with precision genome editing.Biochemical Society transactions · 2024
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Karl Petri *Molecular Pathology Unit and Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA, USA.ORCID http://orcid.org/0000-0002-9624-3976
Weiting Zhang *Cardiovascular Research Center, Massachusetts General Hospital, Charlestown, MA, USA.
Junyan Ma *Cardiovascular Research Center, Massachusetts General Hospital, Charlestown, MA, USA.
Andrea Schmidts *Department of Medicine, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0001-7035-1584
Hyunho LeeMolecular Pathology Unit and Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA, USA.
Joy E HorngMolecular Pathology Unit and Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA, USA.ORCID http://orcid.org/0000-0001-7702-7381
Daniel Y KimMolecular Pathology Unit and Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA, USA.ORCID http://orcid.org/0000-0002-6273-7310
Ibrahim C KurtMolecular Pathology Unit and Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA, USA.ORCID http://orcid.org/0000-0003-3927-0991
Kendell ClementMolecular Pathology Unit and Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA, USA.ORCID http://orcid.org/0000-0003-3808-0811
Jonathan Y HsuMolecular Pathology Unit and Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA, USA.ORCID http://orcid.org/0000-0002-1342-5628
Luca PinelloMolecular Pathology Unit and Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA, USA.
Marcela V MausDepartment of Medicine, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0002-7578-0393
J Keith JoungMolecular Pathology Unit and Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA, USA. jjoung@mgh.harvard.edu.ORCID http://orcid.org/0000-0001-5630-5645
Jing-Ruey Joanna YehCardiovascular Research Center, Massachusetts General Hospital, Charlestown, MA, USA. jyeh1@mgh.harvard.edu.ORCID http://orcid.org/0000-0002-7768-4901

Funding

Center for Genomic Editing and Recording: Development and Application of Next-Generation Genome and Epigenome Editing Methods to Advance the Study and Treatment of Human DiseaseRM1HG009490 · NHGRI · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI Brittany S. Adamson, Martin Joseph Ankrah Aryee · 2017 to 2026
$22.7M
Evolution, Optimization, and Application of Genome Editing TechnologiesR35GM118158 · NIGMS · MASSACHUSETTS GENERAL HOSPITAL · PI JOUNG, J. KEITH · 2016 to 2023
$4.7M
ADVANCING GENE-EDITING NUCLEASES FOR DIVERSE ZEBRAFISH APPLICATIONSR01GM134069 · NIGMS · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI RANDALL T PETERSON · 2019 to 2026
$3.7M
Multiscale exploration of the functional non-coding genomeR35HG010717 · NHGRI · MASSACHUSETTS GENERAL HOSPITAL · PI PINELLO, LUCA · 2019 to 2023
$2.6M
Deutsche Forschungsgemeinschaft (German Research Foundation) 417577129NHGRI NIH HHS R35 HG010717NHGRI NIH HHS RM1 HG009490NIGMS NIH HHS R01 GM134069NIGMS NIH HHS R35 GM118158United States Department of Defense | Defense Advanced Research Projects Agency (DARPA) HR0011-17-2-0042
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID33986547

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.